Citadel Advisors’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.53M | Sell |
33,200
-65,400
| -66% | -$4.71M | ﹤0.01% | 5591 |
|
|
2025
Q4 | $6.29M | Sell |
98,600
-62,000
| -39% | -$3.82M | ﹤0.01% | 3930 |
|
|
2025
Q3 | $10.1M | Buy |
160,600
+106,100
| +195% | +$7.41M | ﹤0.01% | 3250 |
|
|
2025
Q2 | $4.07M | Buy |
54,500
+21,400
| +65% | +$1.68M | ﹤0.01% | 4467 |
|
|
2025
Q1 | $2.92M | Buy |
33,100
+1,400
| +4% | +$132K | ﹤0.01% | 4810 |
|
|
2024
Q4 | $2.89M | Sell |
31,700
-10,600
| -25% | -$1.09M | ﹤0.01% | 4898 |
|
|
2024
Q3 | $4.74M | Buy |
42,300
+21,900
| +107% | +$2.19M | ﹤0.01% | 4024 |
|
|
2024
Q2 | $2M | Buy |
20,400
+4,700
| +30% | +$466K | ﹤0.01% | 5312 |
|
|
2024
Q1 | $1.57M | Sell |
15,700
-22,700
| -59% | -$2M | ﹤0.01% | 6004 |
|
|
2023
Q4 | $3.45M | Buy |
38,400
+18,900
| +97% | +$1.51M | ﹤0.01% | 4410 |
|
|
2023
Q3 | $1.5M | Sell |
19,500
-77,100
| -80% | -$6.4M | ﹤0.01% | 5767 |
|
|
2023
Q2 | $8.09M | Buy |
96,600
+66,600
| +222% | +$5.42M | ﹤0.01% | 2958 |
|
|
2023
Q1 | $2.53M | Buy |
30,000
+6,400
| +27% | +$550K | ﹤0.01% | 4934 |
|
|
2022
Q4 | $1.92M | Sell |
23,600
-26,800
| -53% | -$2.16M | ﹤0.01% | 5559 |
|
|
2022
Q3 | $3.58M | Sell |
50,400
-42,700
| -46% | -$3.84M | ﹤0.01% | 4460 |
|
|
2022
Q2 | $8.36M | Buy |
93,100
+40,800
| +78% | +$4.22M | ﹤0.01% | 2919 |
|
|
2022
Q1 | $5.86M | Sell |
52,300
-4,400
| -8% | -$516K | ﹤0.01% | 3870 |
|
|
2021
Q4 | $6.86M | Buy |
56,700
+38,000
| +203% | +$4.23M | ﹤0.01% | 3758 |
|
|
2021
Q3 | $1.88M | Sell |
18,700
-66,000
| -78% | -$7.28M | ﹤0.01% | 6513 |
|
|
2021
Q2 | $9.89M | Buy |
84,700
+37,600
| +80% | +$4.51M | ﹤0.01% | 3093 |
|
|
2021
Q1 | $5.19M | Buy |
47,100
+27,900
| +145% | +$3.03M | ﹤0.01% | 4174 |
|
|
2020
Q4 | $1.93M | Sell |
19,200
-32,300
| -63% | -$3M | ﹤0.01% | 5428 |
|
|
2020
Q3 | $4.02M | Sell |
51,500
-33,200
| -39% | -$2.5M | ﹤0.01% | 3480 |
|
|
2020
Q2 | $5.9M | Buy |
84,700
+18,500
| +28% | +$1.17M | ﹤0.01% | 2862 |
|
|
2020
Q1 | $3.08M | Sell |
66,200
-7,100
| -10% | -$456K | ﹤0.01% | 3418 |
|
|
2019
Q4 | $5.81M | Sell |
73,300
-2,700
| -4% | -$208K | ﹤0.01% | 2906 |
|
|
2019
Q3 | $5.61M | Buy |
76,000
+9,200
| +14% | +$660K | ﹤0.01% | 2952 |
|
|
2019
Q2 | $5.2M | Sell |
66,800
-10,400
| -13% | -$790K | ﹤0.01% | 3021 |
|
|
2019
Q1 | $5.86M | Buy |
77,200
+20,400
| +36% | +$1.62M | ﹤0.01% | 2770 |
|
|
2018
Q4 | $4.15M | Buy |
56,800
+2,200
| +4% | +$175K | ﹤0.01% | 3047 |
|
|
2018
Q3 | $5.23M | Sell |
54,600
-5,100
| -9% | -$506K | ﹤0.01% | 2949 |
|
|
2018
Q2 | $5.97M | Buy |
59,700
+10,500
| +21% | +$1.11M | ﹤0.01% | 2533 |
|
|
2018
Q1 | $5.2M | Sell |
49,200
-39,800
| -45% | -$4.02M | ﹤0.01% | 2413 |
|
|
2017
Q4 | $8.24M | Buy |
89,000
+32,500
| +58% | +$2.95M | 0.01% | 1919 |
|
|
2017
Q3 | $5.11M | Sell |
56,500
-9,900
| -15% | -$843K | ﹤0.01% | 2285 |
|
|
2017
Q2 | $5.58M | Buy |
66,400
+18,000
| +37% | +$1.45M | ﹤0.01% | 2011 |
|
|
2017
Q1 | $3.91M | Sell |
48,400
-59,600
| -55% | -$4.69M | ﹤0.01% | 2286 |
|
|
2016
Q4 | $8.12M | Buy |
108,000
+4,800
| +5% | +$347K | 0.01% | 1535 |
|
|
2016
Q3 | $6.99M | Sell |
103,200
-20,800
| -17% | -$1.4M | 0.01% | 1673 |
|
|
2016
Q2 | $8.42M | Buy |
124,000
+34,100
| +38% | +$2.51M | 0.01% | 1379 |
|
|
2016
Q1 | $6.49M | Sell |
89,900
-9,800
| -10% | -$642K | 0.01% | 1537 |
|
|
2015
Q4 | $6.73M | Sell |
99,700
-3,800
| -4% | -$266K | 0.01% | 1564 |
|
|
2015
Q3 | $6.7M | Sell |
103,500
-7,300
| -7% | -$539K | 0.01% | 1652 |
|
|
2015
Q2 | $9.07M | Buy |
110,800
+20,600
| +23% | +$1.59M | 0.01% | 1540 |
|
|
2015
Q1 | $6.25M | Sell |
90,200
-20,000
| -18% | -$1.44M | 0.01% | 1807 |
|
|
2014
Q4 | $8.36M | Buy |
110,200
+7,200
| +7% | +$569K | 0.01% | 1542 |
|
|
2014
Q3 | $8.33M | Buy |
103,000
+3,800
| +4% | +$317K | 0.01% | 1517 |
|
|
2014
Q2 | $8.66M | Buy |
99,200
+13,000
| +15% | +$1.13M | 0.01% | 1382 |
|
|
2014
Q1 | $7.43M | Sell |
86,200
-10,800
| -11% | -$885K | 0.01% | 1473 |
|
|
2013
Q4 | $7.83M | Buy |
97,000
+17,200
| +22% | +$1.34M | 0.01% | 1376 |
|
|
2013
Q3 | $6.22M | Buy |
79,800
+31,700
| +66% | +$2.44M | 0.01% | 1424 |
|
|
2013
Q2 | $3.37M | Buy |
+48,100
| New | +$3.35M | 0.01% | 1953 |
|
Other funds holding EMN
VPM
VCM
Citadel Advisors's EMN Position: Q1 2026 in Review
Citadel Advisors reduced its Eastman Chemical (EMN) stake by 82% in Q1 2026, selling an estimated $78.7M and leaving 241,755 shares worth $18.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2421.
Citadel Advisors first reported a position in EMN in Q2 2013 and has held it in 50 quarters since. The position peaked at $136M in Q1 2015. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Citadel Advisors held 241,755 shares of Eastman Chemical worth $18.5M as of Q1 2026.
- Citadel Advisors sold 1,091,337 Eastman Chemical shares in Q1 2026, an estimated $78.7M.
- Eastman Chemical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2421 holding.
- Citadel Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 50 quarters since.
- Citadel Advisors's Eastman Chemical position peaked at $136M in Q1 2015.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.